Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and redox-active substrates are a group of highly reactive oxygen-containing molecules, including superoxide, hydrogen peroxide, and the hydroxyl radical, which are generated as natural byproducts of cellular metabolism (Sies et al., 2017). At physiological levels, they function as vital signaling molecules in processes such as cell proliferation, differentiation, and the immune response (Pizzino et al., 2017). However, excessive accumulation leads to oxidative stress, which causes irreversible damage to cellular components like DNA, lipids, and proteins, contributing to the pathogenesis of cancer, cardiovascular diseases, and neurodegeneration (Frijhoff et al., 2015). Pharmacological intervention typically involves the use of antioxidant scavengers or redox-modulating agents designed to neutralize these species or enhance endogenous antioxidant capacity (DrugBank Online, 2024). While targeting ROS has therapeutic potential, challenges include maintaining the delicate balance of redox signaling and avoiding the disruption of essential physiological functions such as the oxidative burst in phagocytes (Sies et al., 2017).
Drugs targeting these species typically act through direct chemical scavenging, where the drug molecule reacts with and neutralizes the reactive species, or by acting as substrates for antioxidant enzymes to restore cellular redox homeostasis (DrugBank Online, 2024; Sies et al., 2017).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and redox-active substrates (ROS).